Number of men consented to the APCaRI 01 and 03 protocols (1 July 2014 to 30 June 2019) who donated biospecimens and PROM data to the APCaRI Biorepository and Registry respectively, at baseline and years 1–4, categorised by therapy type
Active surveillance | Radical prostatectomy | Radiation therapy | Hormone treatment | Cryotherapy | Total n= | |
Number of patients | 467 | 958 | 725 | 697 | 154 | 3001 |
Baseline biospecimens | 463 | 941 | 716 | 686 | 152 | 2958 |
Biospecimens year 1–4 | 543 | 1274 | 750 | 706 | 229 | 3502 |
Number of patients with disease progression | 167 | 188 | 63 | 157 | 56 | 631 |
Disease progression biospecimens available | 167 | 188 | 63 | 155 | 55 | 628 |
Baseline QoL | 454 | 925 | 708 | 675 | 147 | 2909 |
QoL year 1–4 | 741 | 1638 | 1101 | 1011 | 285 | 4776 |
APCaRI, Alberta Prostate Cancer Research Initiative; PROM, patient-reported outcome measures; QoL, quality of life.